Lipase Protease Amylase (Creon Minimicrospheres, Viokace) shortage status
Widespread shortage
Source: Health Canada shortage reports · Updated Oct 14, 2026
Also sold as: Creon Minimicrospheres, Viokace, Cotazym Ecs, Creon Minimicrospheres Micro
Lipase Protease Amylase is in a widespread shortage in Canada. 5 of 10 reported products are affected. The latest manufacturer estimate for full recovery is May 31, 2027.
Pancreatic enzymes used to help digestion when the pancreas does not produce enough.
Products affected
5 / 10
In shortage since
Jun 8, 2026
Est. full return
May 31, 2027
Reports on file
98
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
DIN 02200104 · ended Dec 13, 2024 · Globally Allocated SKU
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Lipase Protease Amylase is currently affected by 5 active shortage reports filed with Health Canada by BGP PHARMA ULC, ORGANON CANADA INC..
The reported causes are: globally allocated skus; shortage of an active ingredient; demand increase for the drug; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Lipase Protease Amylase is classified under “DIGESTIVES, INCL ENZYMES” (ATC A09AA).
Recent changes
Oct 14, 2026
Status changed
Oct 14, 2026
Shortage resolved
Oct 9, 2026
Status changed
Oct 9, 2026
Estimated end date pushed back : Feb 28, 2027 → May 31, 2027
Oct 9, 2026
Status changed
Oct 9, 2026
Estimated end date pushed back : Feb 28, 2027 → May 31, 2027
Oct 9, 2026
Estimated end date pushed back : Feb 28, 2027 → May 31, 2027
Oct 6, 2026
New report filed
Oct 6, 2026
New report filed
Oct 6, 2026
Estimated end date moved earlier : Nov 10, 2026 → Nov 3, 2026
Sep 29, 2026
Estimated end date pushed back : Nov 2, 2026 → Nov 10, 2026
Sep 25, 2026
New report filed
Sep 22, 2026
New report filed
Common questions
What is Lipase Protease Amylase used for?
Pancreatic enzymes used to help digestion when the pancreas does not produce enough.
When will Lipase Protease Amylase be back in stock in Canada?
The latest manufacturer estimate is May 31, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Lipase Protease Amylase in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.